https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Study Explores the Survival Advantage of GLP-1s in Cancer Patients With Diabetes

Study Explores the Survival Advantage of GLP-1s in Cancer Patients With Diabetes

GLP-1 receptor agonists show promise in improving survival rates for older cancer patients with type 2 diabetes (T2D), highlighting their potential in oncology.

administrator

Related Articles